Finance

Lists
MDXG:NASDAQ
MiMedx Group Inc
$4.30
-1.04%
(-0.045) 1D
Aug 10, 3:35:58 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDXG...
Open
$4.31
High
$4.39
Low
$4.22
Mkt. cap
626.04M
Avg. vol.
1.53M
Volume
583.09K
P/E ratio
108.76
52-wk high
$7.97
52-wk low
$3.02
EPS
$0.04
Beta
1.45
Shares outstanding
145.76M
No. of employees
808
Open
$4.31
High
$4.39
Low
$4.22
Mkt. cap
626.04M
Avg. vol.
1.53M
Volume
583.09K
P/E ratio
108.76
52-wk high
$7.97
52-wk low
$3.02
EPS
$0.04
Beta
1.45
Shares outstanding
145.76M
No. of employees
808
About MiMedx Group Inc
CEOTimothy R Wright
Employees808
Founded2006
HeadquartersMarietta, Georgia, United States
SectorBiotechnology
Websitemimedx.com
Analyst ratings
Based on 2 analysts giving stock ratings to MDXG in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MDXG in the last 3 months.
Highest
Current $4.30
$7.00 (+62.98%)
Average
$7.00 (+62.98%)
Lowest
$7.00 (+62.98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Buy
Reiterated
$7.00
+63%
07/30/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
07/06/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$8.00
+86.3%
04/30/2026
Brooks O'Neil
Lake Street
Buy
Maintained
$5.00
+16.4%
04/30/2026
David Turkaly
Citizens JMP
Buy
Maintained
$6.00
+39.7%
04/30/2026
Carl Byrnes
Northland Securities
Buy
Maintained
$6.00
+39.7%
04/17/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$8.00
+86.3%
02/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
113.72M
118.10M
58.99M
64.36M
Cost of goods sold
18.72M
19.06M
17.37M
19.98M
Cost of revenue
18.72M
19.06M
17.37M
19.98M
Research and development expenses
3.70M
4.76M
4.14M
2.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.00M
73.07M
53.23M
59.78M
Operating expense
72.82M
77.96M
57.67M
62.85M
Total operating expenses
91.54M
97.02M
75.04M
82.83M
Operating income
22.19M
21.08M
-16.05M
-18.47M
Other non operating income
-126.00K
-186.00K
-168.00K
-102.00K
EBT including unusual items
22.85M
21.80M
-15.33M
-17.78M
EBT excluding unusual items
22.85M
21.80M
-15.33M
-17.78M
Income tax expense
6.10M
6.60M
-4.47M
-2.94M
Effective tax rate
26.70%
30.30%
29.16%
16.54%
Other operating expenses
-
-
-
-
Net income
16.75M
15.19M
-10.86M
-14.84M
Net profit margin
14.73%
12.86%
-18.41%
-23.06%
Earnings per share
0.15
0.14
-0.05
-0.05
Interest and investment income
1.21M
1.31M
1.29M
1.17M
Interest expense
-425.00K
-405.00K
-402.00K
-386.00K
Net interest expenses
785.00K
904.00K
886.00K
788.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
27.48M
24.30M
-14.43M
-16.94M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps